BETHLEHEM, Pa., Dec. 1, 2022
/PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart
infusion therapy and safe and effective pharmacy products,
announced today that its macro and micro compounder – the
APEX® Compounding System – and its proprietary TPN
Manager Clinical Decision Support Order Entry Software will be
demonstrated at the ASHP Midyear Meeting December 5-7 at the Mandalay Bay Convention
Center, Las Vegas in the B. Braun
Executive Suite.
TPN Manager software incorporates Trissel's™ Ca/P
check to help minimize the risk of precipitation and allows users
to create templates to standardize their order format. Also
featured are dosing limits to alert and prevent prescribers from
ordering doses of ingredients that exceed recommended or safe
clinical limits. Since TPN Manager is browser-based, healthcare
providers can enter parenteral nutrition orders at the patient's
bedside using a tablet computer and electronically transmit those
orders directly to pharmacy for authorization. The order then
automatically routes to the APEX compounder without the need for
transcription.
"The direct communication is designed to help reduce manual
programming errors, eliminate transcription errors and expedite
patient care," said Jessica Pitt,
Product Director, Automated Compounding Systems.
The APEX Compounding System was specifically designed to address
the immediate needs of critically ill patients – from neonates to
adults – while also meeting the critical needs of pharmacists.
Safety, accuracy and efficiency are the key drivers behind its
unique design. From its large user interface and 26-lead
preassembled sets to its dual-drive filling technology, APEX is
designed to facilitate a smoother compounding process.
"With APEX's 26 ports and ability to accurately deliver volumes
as low as 0.2 mL, pharmacists now have the opportunity to automate
the majority of the compounding process," Pitt said. "APEX is
unique as the only automated compounder with the ability to track
and verify manual additions. This helps to improve patient safety
since ingredients like insulin, a high-alert medication, are
frequently added manually to parenteral nutrition
orders."
To reserve an advance appointment to experience the APEX
Compounding System with TPN Manager, attendees can visit the APEX
Executive Suite Booking Site to secure an individual demo time or
visit booth #1323 during the show.
For more information on the APEX Compounding System, visit
www.bbraunusa.com/apex.
About B. Braun
B. Braun Medical Inc. (B. Braun)
is a leader in smart infusion therapy and safe and effective
pharmacy products, patient and provider safety, and sustainable
health solutions. Our purpose is to help providers constantly
improve patient satisfaction and outcomes. With products and
services created to help healthcare professionals focus on what
matters most—their patients—we're uniquely positioned to help
health systems succeed now and in the future. B. Braun is
headquartered in Bethlehem,
Pennsylvania and is part of the B. Braun Group of Companies
in the U.S., which includes B. Braun Interventional
Systems, Aesculap® and
CAPS®. The company employs 8,500 people at
over 30 locations across North
America.
Globally, the B. Braun Group of Companies employs more than
64,000 employees in 64 countries. Guided by its Sharing
Expertise® philosophy, B. Braun continuously
exchanges knowledge with customers, partners and clinicians to
address the critical issues of improving care and lowering costs.
To learn more about B. Braun Medical, explore our website.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/b-braun-will-showcase-its-apex-compounding-system-with-clinical-decision-support-order-entry-software-at-the-ashp-midyear-meeting-and-exhibition-301692090.html
SOURCE B. Braun Medical Inc.